These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7026270)

  • 21. A shortened insulin with full in vitro potency.
    Fischer WH; Saunders D; Brandenburg D; Wollmer A; Zahn H
    Biol Chem Hoppe Seyler; 1985 May; 366(5):521-5. PubMed ID: 3890892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin.
    Burke GT; Chanley JD; Okada Y; Cosmatos A; Ferderigos N; Katsoyannis PG
    Biochemistry; 1980 Sep; 19(20):4547-56. PubMed ID: 7000179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-function relationships of des-(B26-B30)-insulin.
    Spoden M; Gattner HG; Zahn H; Brandenburg D
    Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo potency of insulin analogues designed for clinical use.
    Vølund A; Brange J; Drejer K; Jensen I; Markussen J; Ribel U; Sørensen AR; Schlichtkrull J
    Diabet Med; 1991 Nov; 8(9):839-47. PubMed ID: 1663018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymatic semisynthesis of porcine despentapeptide (B26-30) insulin using unprotected desoctapeptide (B23-30) insulin as a substrate. Model studies.
    Kubiak T; Cowburn D
    Int J Pept Protein Res; 1986 May; 27(5):514-21. PubMed ID: 3525439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [LeuB24]- and [LeuB25]insulins are not antagonists of lipogenesis in adipocytes.
    Diaconescu C; Saunders D; Gattner HG; Brandenburg D
    Hoppe Seylers Z Physiol Chem; 1982 Feb; 363(2):187-92. PubMed ID: 7037593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of insulin fragments on biological activity of insulin and desoctapeptide insulin. II. Enhanced binding and mechanism studies.
    Kikuchi K; Larner J; Freer RJ; Day AR
    J Biol Chem; 1981 Sep; 256(18):9445-9. PubMed ID: 7026554
    [No Abstract]   [Full Text] [Related]  

  • 28. Preparation of semisynthetic insulin analogues from bis(tert-butyloxycarbonyl)-desoctapeptide-insulin phenylhydrazide: importance of the aromatic region B24-B26.
    Riemen MW; Pon LA; Carpenter FH
    Biochemistry; 1983 Mar; 22(6):1507-15. PubMed ID: 6340739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor binding and biological activity of [SerB24]-insulin, an abnormal mutant insulin.
    Kobayashi M; Haneda M; Maegawa H; Watanabe N; Takada Y; Shigeta Y; Inouye K
    Biochem Biophys Res Commun; 1984 Feb; 119(1):49-57. PubMed ID: 6367745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [B17-D-leucine]insulin and [B17-norleucine]insulin: synthesis and biological properties.
    Knorr R; Danho W; Büllesbach EE; Gattner HG; Zahn H; King GL; Kahn CR
    Hoppe Seylers Z Physiol Chem; 1983 Nov; 364(11):1615-26. PubMed ID: 6363268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Internalization and degradation of a low affinity insulin ([LeuB24]insulin) by rat adipocytes.
    Green A; Tager H; Rubenstein A; Frank B; Olefsky JM
    FEBS Lett; 1982 Aug; 144(2):255-8. PubMed ID: 6749549
    [No Abstract]   [Full Text] [Related]  

  • 32. An insulin with the native sequence but virtually no activity.
    Wollmer A; Gilge G; Brandenburg D; Gattner HG
    Biol Chem Hoppe Seyler; 1994 Mar; 375(3):219-22. PubMed ID: 8011179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of N-methylation of selected peptide bonds on the biological activity of insulin. [2-N-methylisoleucine-A]insulin and [3-N-methylvaline-A]insulin.
    Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
    Int J Pept Protein Res; 1987 Oct; 30(4):460-73. PubMed ID: 3323092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
    Burke GT; Schwartz G; Katsoyannis PG
    Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
    Stümpel F; Hartmann H; Brandenburg D; Creutzfeldt W
    Diabetes Res Clin Pract; 1990 Jul; 9(3):257-64. PubMed ID: 2226126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An examination of the role of insulin dimerisation and negative cooperativity using the biological properties of the despentapeptide and deshexapeptide insulins.
    Cockram CS; Jones RH; Sonksen PH; Tatnell MA; Zhu SQ; Dodson G
    Diabetologia; 1987 Sep; 30(9):733-8. PubMed ID: 3322916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity.
    Kobayashi M; Ohgaku S; Iwasaki M; Maegawa H; Shigeta Y; Inouye K
    Biochem J; 1982 Sep; 206(3):597-603. PubMed ID: 6756393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of binding of a low affinity, noncooperative insulin [( LeuB25]insulin) to IM-9 lymphocytes.
    Green A; Frank BH; Rubenstein A; Tager H; Olefsky JM
    Endocrinology; 1983 Dec; 113(6):1963-71. PubMed ID: 6357764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions.
    Mirmira RG; Nakagawa SH; Tager HS
    J Biol Chem; 1991 Jan; 266(3):1428-36. PubMed ID: 1988428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semisynthesis of insulin: specific activation of the arginine carboxyl group of the B chain of desoctapeptide-(B23--30)-insulin (bovine).
    Canova-Davis E; Carpenter FH
    Biochemistry; 1981 Nov; 20(24):7053-8. PubMed ID: 7032587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.